Line 226: |
Line 226: |
| | | | | |
| |- | | |- |
− | |'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident | + | |'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident) |
| |Jennelle Hodge (JH)/ Malini Sathanoori (MS) | | |Jennelle Hodge (JH)/ Malini Sathanoori (MS) |
| |Complete | | |Complete |
Line 237: |
Line 237: |
| | | | | |
| |- | | |- |
− | | Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH / MS | + | | Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)||JH / MS |
| |PENDING | | |PENDING |
| | | | | |
Line 262: |
Line 262: |
| | | | | |
| |- | | |- |
− | | Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+Path Resident||JH / MS | + | | Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)||JH / MS |
| |Complete | | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | |'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident | + | |'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee) |
| |JH / MS | | |JH / MS |
| |Complete | | |Complete |
Line 308: |
Line 308: |
| | | | | |
| |- | | |- |
− | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy via Greg Conboy (Monash Health)||JH / MS | + | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS |
| |Complete | | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | | Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH / MS | + | | Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS |
| |Complete | | |Complete |
| | | | | |
| |Add WHO reference | | |Add WHO reference |
| |- | | |- |
− | | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg Conboy (Monash Health)||JH / MS | + | | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg Conboy (Monash Health)||JH / MS |
| |Complete | | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | | Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Path Resident (Iris Martin)||JH / MS | + | | Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)||JH / MS |
| |Complete | | |Complete |
| | | | | |
Line 333: |
Line 333: |
| | | | | |
| |- | | |- |
− | |Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH / MS | + | |Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)||JH / MS |
| |Complete | | |Complete |
| | | | | |
| |Check reference format | | |Check reference format |
| |- | | |- |
− | |''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS | + | |''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS |
| |Complete | | |Complete |
| | | | | |
Line 383: |
Line 383: |
| | | | | |
| |- | | |- |
− | | Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH / MS | + | | Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH / MS |
| |Complete | | |Complete |
| | | | | |
Line 408: |
Line 408: |
| | | | | |
| |- | | |- |
− | |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH / MS | + | |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)||JH / MS |
| |Complete | | |Complete |
| | | | | |
Line 418: |
Line 418: |
| | | | | |
| |- | | |- |
− | | Acute Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH / MS | + | | Acute Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)||JH / MS |
| |Complete | | |Complete |
| | | | | |
Line 433: |
Line 433: |
| | | | | |
| |- | | |- |
− | | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH / MS | + | | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)||JH / MS |
| |Complete | | |Complete |
| | | | | |
Line 455: |
Line 455: |
| |Acute Myeloid Leukemia (AML) with Mutated FLT3 | | |Acute Myeloid Leukemia (AML) with Mutated FLT3 |
| |Disease | | |Disease |
− | |Kay Weng Choy via Greg Conboy (Monash Health) | + | |Kay Weng Choy + Greg Conboy (Monash Health) |
| |JH / MS | | |JH / MS |
| |Complete | | |Complete |
Line 463: |
Line 463: |
| |Acute Myeloid Leukemia (AML) with NUP214-ABL1 | | |Acute Myeloid Leukemia (AML) with NUP214-ABL1 |
| |Disease | | |Disease |
− | |Daynna Wolff+Path Resident | + | |Daynna Wolff+Jessica Snider (Path Resident) |
| |JH / MS | | |JH / MS |
| |PENDING | | |PENDING |
Line 471: |
Line 471: |
| |Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | | |Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 |
| |Disease | | |Disease |
− | |Daynna Wolff+Path Resident | + | |Daynna Wolff+ Paige Woodham (Path Resident) |
| |JH / MS | | |JH / MS |
| |PENDING | | |PENDING |